Analyst Ratings for Forest Laboratories (FRX) [Buys]
FRX Rating Summary
FRX Price Target Summary
- Highest: $45.00 (Cantor Fitzgerald)
- Lowest: $27.00 (BMO Capital)
- Average: $38.13
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$38.13 (-2.1%)
Avg. $ Target:
$38.13 (-2.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2013 | Janney Montgomery Scott | New Coverage | Buy (N/A) |
45.00 (N/A) |
36.28 | 38.96 | 7.39% | Details |
| 12/10/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
35.72 | 38.96 | 9.07% | Details |
| 11/30/2012 | Citi | New Coverage | Buy (N/A) |
40.00 (N/A) |
34.58 | 38.96 | 12.67% | Details |
| 11/9/2012 | Mizuho Securities | New Coverage | Buy (N/A) |
45.00 (N/A) |
32.96 | 38.96 | 18.2% | Details |
| 5/31/2012 | Leerink Swann | Upgrade | Outperform (N/A) |
41.00 (N/A) |
33.66 | 38.96 | 15.75% | Details |
| 12/6/2011 | Cantor Fitzgerald » Updated 4/18/2012 |
New Coverage | Buy (N/A) |
45.00 (N/A) |
29.87 | 38.96 | 30.43% | Details |
| 10/6/2011 | ThinkEquity | New Coverage | Buy (N/A) |
38.00 (N/A) |
31.18 | 38.96 | 24.95% | Details |
| 6/17/2011 | Caris & Co. | Downgrade | Above Average (N/A) |
N/A (N/A) |
38.53 | 38.96 | 1.12% | Details |
| 4/14/2011 | Credit Suisse | Upgrade | Outperform (N/A) |
N/A (N/A) |
33.89 | 38.96 | 14.96% | Details |
